Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/ß-catenin signaling.

Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/ß-catenin signaling. PLoS One. 2013; 8(3):e56959.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.